Chinese e-commerce giant Alibaba Group Holding Ltd (NYSE:BABA) says it has spent more than $160m (£103m) fighting fake goods on its websites from the beginning of 2013 to November of this year. Alibaba Group Holding Ltd (NYSE:BABA) belongs to Services sector. Its net profit margin is 46.30% and weekly performance is -0.24%. On last trading day company shares ended up $105.52. Alibaba Group Holding Ltd (NYSE:BABA) distance from 50-day simple moving average (SMA50) is 0.77%.

The U.S. credit union regulator sued Wells Fargo & Company (NYSE:WFC) Tuesday, saying the bank failed to fulfill its duties as a trustee for certain residential mortgage-backed securities trusts that soured and brought down five credit unions. Wells Fargo & Company (NYSE:WFC) shares advanced 0.91% in last trading session and ended the day at $55.47. WFC return on assets is 1.40%. Wells Fargo & Company (NYSE:WFC) quarterly performance is 7.11%.

Capella Education Co. (NASDAQ:CPLA) begin trading ex-dividend on December 22, 2014. A cash dividend payment of $0.37 per share is scheduled to be paid on January 15, 2015. On 23 December, Capella Education Co. (NASDAQ:CPLA) shares advanced 0.04% and was closed at $74.98. CPLA EPS growth in last 5 year was 11.00%. Capella Education Co. (NASDAQ:CPLA) year to date (YTD) performance is 15.44%.

Hamilton Beach Brands, Inc, a wholly owned subsidiary of NACCO Industries, Inc. (NYSE:NC), announced it acquired Weston Products, LLC from Highgate Capital LLC. Weston Products, which will become Weston Brands under Hamilton Beach Brands, is headquartered in Strongsville, Ohio and is a leader in wild game processing equipment. Nacco Industries Inc. (NYSE:NC) ended the last trading day at $56.99. Company weekly volatility is calculated as 2.85% and price to cash ratio as 8.22. Nacco Industries Inc. (NYSE:NC) showed a weekly performance of 3.34%.

Synageva BioPharma Corp. (NASDAQ:GEVA), announced validation by the European Medicines Agency (EMA) of the Marketing Authorization Application (MAA) for sebelipase alfa for LAL Deficiency. The EMA recently granted the company’s request for accelerated assessment, which has the potential to shorten the EMA’s regulatory review time. Synageva BioPharma Corp. (NASDAQ:GEVA) shares fell -5.84% in last trading session and ended the day at $89.74. GEVA return on assets is -29.90%. Synageva BioPharma Corp. (NASDAQ:GEVA) quarterly performance is 36.42%.